JLJosé Angel Cigarroa López

José Angel Cigarroa López

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


José Angel Cigarroa López has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Awareness, attitudes, and barriers toward Transthyretin Amyloid Cardiomyopathy in Latin America: A questionnaire-based cross-sectional study

    by Cecilia Camacho-Hubner, Marcia Waddington-Cruz, María Juliana Rodríguez-González, Marcus Vinicius Simões, Juan David López-Ponce de León, Fabio Fernandes, Erika María Martínez-Carreño, Juan Pablo Costabel, Enrique A. Berrios-Bárcenas, Fabio Barroso, et al.

    Background: Cardiac Amyloidosis (CA), specifically Transthyretin Amyloid Cardiomyopathy (ATTR-CM), is an under-recognized, progressive, and fatal disease. Comprehensive primary data describing awareness, attitudes, and barriers to treatment in Latin America (LATAM) are lacking, highlighting a gap between guidelines and real-world clinical practice. Methods: A cross-sectional, questionnaire-based observational study was conducted among 470 physicians actively involved in patient management across 8 LATAM countries (June-August 2023). The study assessed their awareness, attitudes, and barriers concerning ATTR-CM. Descriptive analysis was performed. Results: Limited knowledge of ATTR-CM was observed. Awareness of its pathophysiology was reported by 50.2%. Patients consulted 4–5 physicians before receiving a confirmed diagnosis. Cardiologists managed most day-to-day cases (76.2%). Transthyretin genetic testing was available to only 26.4%. Local treatment protocols relied on international guidelines (87.4%), with Real-World Data considered important by 60.6%. Patient cost and access to tafamidis were frequently reported barriers. Follow-up commonly relied on echocardiography, NT-pro BNP, NYHA classification, and ECG/Holter ECG. Conclusions: Difficulties in ATTR-CM diagnosis and management in LATAM were influenced by varying knowledge levels, gaps in diagnostic algorithms, and significant access barriers. These factors contribute to delayed diagnosis and management. Enhanced, tailored training strategies and collaborative efforts are necessary to improve early diagnosis, effective treatment, and ultimately, patient outcomes in the region.

  • Open Access

    [Blood transfusion in patients undergoing heart transplant surgery].

    by Aide Alejandra Toledo-González, Esmeralda Campos-Aguirre, José Ángel Cigarroa-López

    In patients undergoing cardiac surgery, one of the most common complications is bleeding. There are risk factors associated with bleeding and transfusion during or after cardiac surgery. The decision of blood transfusion depends on the individualized characteristics of each patient. To determine the characteristics that influenced blood transfusion, aside from the frequency and proportion of the use of blood components. We identified patients who underwent heart transplant surgery and the frequency of those who required transfusion. The proportion of the use of blood components, the characteristics of the surgical intervention and factors that influenced transfusion and mortality were determined. We included 19 patients who underwent heart transplant surgery. 89.5% received blood transfusion. The mean amount of blood products used during surgery and hospitalization was 2.10 red blood cells, 1.10 fresh frozen plasma and 0.89 apheresis platelets. The odds ratio for transfusion in surgery was 1.4 for mortality. 89.5% of the patients required blood transfusion either in surgery (73.7%) or during hospitalization (68.4%). Age, cardiopulmonary bypass time, and length of stay represented risk for transfusion. Age over 45 years and transfusion in hospitalization increase the risk of mortality.